{
    "root": "a0df61ac-b037-40fc-a889-90de12c99010",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Lansoprazole",
    "value": "20250311",
    "ingredients": [
        {
            "name": "LANSOPRAZOLE",
            "code": "0K5C5T2QPG"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "2165RE0K14"
        },
        {
            "name": "MAGNESIUM CARBONATE",
            "code": "0E53J927NA"
        },
        {
            "name": "METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER",
            "code": "NX76LV5T8J"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "RAW SUGAR",
            "code": "8M707QY5GH"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        }
    ],
    "indications": "lansoprazole delayed-release capsule proton pump inhibitor ( ppis ) indicated : \u2022 treatment active duodenal ulcer adults . ( 1.1 ) \u2022 eradication h. pylori reduce risk duodenal ulcer recurrence adults . ( 1.2 ) \u2022 maintenance healed duodenal ulcers adults . ( 1.3 ) \u2022 treatment active benign gastric ulcer adults . ( 1.4 ) \u2022 healing nonsteroidal anti-inflammatory drugs ( nsaid ) -associated gastric ulcer adults . ( 1.5 ) \u2022 risk reduction nsaid-associated gastric ulcer adults . ( 1.6 ) \u2022 treatment symptomatic gastroesophageal reflux disease ( gerd ) adults pediatric patients 1 year age older . ( 1.7 ) \u2022 treatment erosive esophagitis ( ee ) adults pediatric patients 1 year age older . ( 1.8 ) \u2022 maintenance healing ee adults . ( 1.9 ) \u2022 pathological hypersecretory conditions , including zollinger-ellison syndrome ( zes ) adults . ( 1.10 )",
    "contraindications": "recommended : \u2022 full prescribing information complete dosing information lansoprazole delayed-release capsule indication age group adjustment patients severe hepatic impairment . ( 2.1 , 2.2 , 2.3 ) instructions ( 2.4 ) lansoprazole delayed-release capsules \u2022 swallowed whole . \u2022 full prescribing information alternative options .",
    "warningsAndPrecautions": "lansoprazole delayed release capsules usp , 30 mg white pale yellow colored enteric coated pellets filled size \u2018 1 \u2019 hard gelatin capsules opaque pink colored cap opaque black colored body , imprinted \u2018 rdy \u2019 cap \u2018 399 \u2019 body white ink . supplied cartons 80 delayed release capsules ( 10 delayed release capsules blister pack x 8 ) , ndc 0904-6662-45",
    "adverseReactions": "\u2022 lansoprazole delayed-release capsules contraindicated patients known severe hypersensitivity component formulation . hypersensitivity may include anaphylaxis , anaphylactic shock , angioedema , bronchospasm , acute tubulointerstitial nephritis , urticaria [ ( 5.2 ) , ( 6 ) ] . \u2022 proton pump inhibitors ( ppis ) , including lansoprazole delayed-release capsules contraindicated rilpivirine-containing products [ ( 7 ) ] . \u2022 information antibacterial agents ( clarithromycin amoxicillin ) indicated combination lansoprazole delayed-release capsules , refer section prescribing information .",
    "indications_original": "Lansoprazole delayed-release capsule is a proton pump inhibitor (PPIs) indicated for the: \u2022 Treatment of active duodenal ulcer in adults. ( 1.1 ) \u2022 Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults. ( 1.2 ) \u2022 Maintenance of healed duodenal ulcers in adults. ( 1.3 ) \u2022 Treatment of active benign gastric ulcer in adults. ( 1.4 ) \u2022 Healing of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults. ( 1.5 ) \u2022 Risk reduction of NSAID-associated gastric ulcer in adults. ( 1.6 ) \u2022 Treatment of symptomatic gastroesophageal reflux disease (GERD) in adults and pediatric patients 1 year of age and older.( 1.7 ) \u2022 Treatment of erosive esophagitis (EE) in adults and pediatric patients 1 year of age and older. ( 1.8 ) \u2022 Maintenance of healing of EE in adults. ( 1.9 ) \u2022 Pathological hypersecretory conditions, including Zollinger-Ellison syndrome (ZES) in adults. ( 1.10 )",
    "contraindications_original": "Recommended Dosage: \u2022 See full prescribing information for complete dosing information for lansoprazole delayed-release capsule by indication and age group and dosage adjustment in patients with severe hepatic impairment. ( 2.1 , 2.2 , 2.3 ) Administration Instructions ( 2.4 ) Lansoprazole delayed-release capsules \u2022 Should be swallowed whole. \u2022 See full prescribing information for alternative administration options.",
    "warningsAndPrecautions_original": "Lansoprazole delayed release capsules USP, 30 mg are white to pale yellow colored enteric coated pellets filled in size \u20181\u2019 hard gelatin capsules with opaque pink colored cap and opaque black colored body, imprinted \u2018RDY\u2019 on cap and \u2018399\u2019 on body with white ink. They are supplied\n                  Cartons of 80 delayed release capsules (10 delayed release capsules each blister pack x 8), NDC 0904-6662-45",
    "adverseReactions_original": "\u2022 Lansoprazole delayed-release capsules are contraindicated in patients with known severe hypersensitivity to any component of the formulation. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see Warnings and Precautions (5.2),Adverse Reactions  (6)\n                        ]. \u00a0 \n                     \n                        \u2022 Proton Pump Inhibitors (PPIs), including lansoprazole delayed-release capsules are contraindicated with rilpivirine-containing products [see Drug Interactions (7\n                        )]. \u00a0 \n                     \n                        \u2022 For information about contraindications of antibacterial agents (clarithromycin and amoxicillin) indicated in combination with lansoprazole delayed-release capsules, refer to the Contraindications section of their prescribing information."
}